tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
IMUNON, Inc. Reports Q3 2025 Results and Progress
PremiumCompany AnnouncementsIMUNON, Inc. Reports Q3 2025 Results and Progress
3M ago
Imunon, Inc. Earnings Call Highlights Progress and Challenges
Premium
Company Announcements
Imunon, Inc. Earnings Call Highlights Progress and Challenges
3M ago
Imunon reports Q3 EPS ($1.16) vs ($3.76) last year
Premium
The Fly
Imunon reports Q3 EPS ($1.16) vs ($3.76) last year
3M ago
Imunon, Inc. Advances Phase 3 Trial for Innovative Cancer Treatment
PremiumCompany AnnouncementsImunon, Inc. Advances Phase 3 Trial for Innovative Cancer Treatment
3M ago
Imunon, Inc. Advances Phase II Study on IMNN-001 for Ovarian Cancer
Premium
Company Announcements
Imunon, Inc. Advances Phase II Study on IMNN-001 for Ovarian Cancer
3M ago
Imunon to present Phase 3 OVATION trial of IMNN-001
Premium
The Fly
Imunon to present Phase 3 OVATION trial of IMNN-001
4M ago
Imunon, Inc. Advances Phase 3 Trial for Innovative Cancer Treatment
PremiumCompany AnnouncementsImunon, Inc. Advances Phase 3 Trial for Innovative Cancer Treatment
6M ago
Imunon, Inc.’s Phase II Study on IMNN-001: A Potential Game-Changer in Ovarian Cancer Treatment?
Premium
Company Announcements
Imunon, Inc.’s Phase II Study on IMNN-001: A Potential Game-Changer in Ovarian Cancer Treatment?
6M ago
Imunon, Inc.’s Ongoing Clinical Trial: Potential Game-Changer for Ovarian Cancer Treatment?
Premium
Company Announcements
Imunon, Inc.’s Ongoing Clinical Trial: Potential Game-Changer for Ovarian Cancer Treatment?
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100